The National Biodefense Science Board (NBSB) will convene for a virtual meeting on 28 August 2023. The NBSB provides expert advice and guidance to the U.S. Department of Health and Human Services and the Assistant Secretary of Preparedness and Response regarding current and future chemical, biological, radiological, and nuclear threats, as well as other matters
A closed meeting of the National Institute of Allergy and Infectious Diseases (NIAID) Special Emphasis Panel will be held September 1, 2023 to review and evaluate contract proposals for the NIAID 2023 DMID Omnibus BAA (HHS–NIH–NIAID–BAA2023–1), Research Area 001—Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases. The meeting will be closed to the
The Oak Ridge Institute for Science and Education (ORISE) will host a Genomics and Precision Public Health Issues Enrichment Event from 7-8 Sep 2023 in Atlanta, Georgia. In the past decade, genomics, and precision health approaches such as big data science and machine learning have emerged as important tools for public health. Those entering the
2023 Scientific Computing Days Sharing and Collaboration in the Data Multiverse:Scientific Computing for Public Health Solutions The 11th annual Scientific Computing Days symposium is a conference promoting the latest advances in scientific computing technologies. The event’s goal is to help FDA improve the application of technology and scientific computing in support of the FDA’s public
The CDC will host the OneLab Summit 2023 from 3-5 October 2023 online. This free, three-day virtual summit connects laboratory professionals in real time to support a unified response to laboratory training needs. Attendance is open to anyone interested or involved in the laboratory profession. OneLab Summit programming is most relevant to people who provide
The annual BARDA Industry Day (BID) conference will be held 13-14 November 2023 in Washington DC and via virtual participation. BID2023: Driving Innovation for Preparedness & Response will feature presentations from BARDA leadership, U.S. government partners, and industry on medical countermeasure (MCM) priorities and public health innovation. Attendees will also have an informal opportunity to
The 24th Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) public meeting will be held virtually on February 22, 2024. This will be the second of two meetings to address the task provided to the PACCARB by the Secretary of HHS to address antimicrobial resistance globally. The focus of the meeting will be on international
A Joint Industry Day for the Rapid Access to Products in Development (RAPID) program to be held virtually on 23 Feb 2024. The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense, Enabling Biotechnologies (JPEO-CBRND-EB), develops, manufactures and delivers safe and effective Medical Countermeasures (MCMs) for preparedness, prevention, protection, response, and recovery from
The CDC's Advisory Committee on Immunization Practices (ACIP) will convene 28-29 February 2024 in Atlanta, GA and via webcast. The ACIP develops recommendations for U.S. immunizations, including ages when vaccines should be given, number of doses, time between doses, and precautions and contraindications. The agenda will include the following: Update on chikungunya vaccine licensure and
